The global Cutaneous Leishmaniasis Drugs market was valued at US$ 44 million in 2022 and is projected to reach US$ 58 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered ...
read more..